open access

Vol 26, No 4 (2019)
Original articles — Clinical cardiology
Submitted: 2017-06-26
Accepted: 2017-11-08
Published online: 2017-12-14
Get Citation

Evaluation of left ventricular function in overweight children and teenagers with arterial hypertension and white coat hypertension

Tomasz Floriańczyk1, Małgorzata Gołąbek-Dylewska1, Beata Kucińska1, Bożena Werner1
·
Pubmed: 29240959
·
Cardiol J 2019;26(4):343-349.
Affiliations
  1. Department of Pediatric Cardiology and General Pediatrics. Medical University of Warsaw, Poland

open access

Vol 26, No 4 (2019)
Original articles — Clinical cardiology
Submitted: 2017-06-26
Accepted: 2017-11-08
Published online: 2017-12-14

Abstract

Background: Obesity in childhood is strongly associated with elevated arterial blood pressure and risk of hypertension. The aim of the study was the evaluation of left ventricular (LV) function in hypertensive and white coat hypertensive overweight children and teenagers.

Methods: The study group consisted of 74 overweight patients aged 10.3 ± 3.1 years (range: 6–16 years) diagnosed as hypertensive in standard blood pressure measurement. The control group consisted of 31 normotensive and normoweight children. Ambulatory blood pressure monitoring (ABPM) and echocardiographic assessment of the LV mass and function were performed in all participants.

Results: Using ABPM hypertension was confirmed in 20 (27%) children. In the 54 (73%) remaining children white coat hypertension was diagnosed. The analysis of echocardiographic parameters revealed higher LV mass index (LVMI) in hypertensive overweight than in normotensive normoweight children (47.5 ± 9.2 g/m2.7 vs. 39.8 ± 12.1 g/m2.7; p < 0.05) and no difference between overweight hypertensive and white coat hypertension-hypertensive groups. The deceleration time of mitral early filling (DCT) was longer in hypertensive normoweight children than in normotensive overweight patients (219.5 ± 110.3 ms vs. 197.8 ± 65.8 ms; p < 0.05). A significant correlation between systolic blood pressure load (SBPL) and DCT (r = 0.57) and moderate correlation between SBPL and LVMI (r: 0.48) as well as between LVMI and isovolumetric relaxation time (r = 0.37) were found.

Conclusions: In overweight children the diagnosis of hypertension should be confirmed in ABPM because of the high prevalence of white coat hypertension. Periodic echocardiographic examinations should be recommended in overweight children with increased SBPL and decreased systolic nocturnal deep because of the possibility of LV function impairment.

Abstract

Background: Obesity in childhood is strongly associated with elevated arterial blood pressure and risk of hypertension. The aim of the study was the evaluation of left ventricular (LV) function in hypertensive and white coat hypertensive overweight children and teenagers.

Methods: The study group consisted of 74 overweight patients aged 10.3 ± 3.1 years (range: 6–16 years) diagnosed as hypertensive in standard blood pressure measurement. The control group consisted of 31 normotensive and normoweight children. Ambulatory blood pressure monitoring (ABPM) and echocardiographic assessment of the LV mass and function were performed in all participants.

Results: Using ABPM hypertension was confirmed in 20 (27%) children. In the 54 (73%) remaining children white coat hypertension was diagnosed. The analysis of echocardiographic parameters revealed higher LV mass index (LVMI) in hypertensive overweight than in normotensive normoweight children (47.5 ± 9.2 g/m2.7 vs. 39.8 ± 12.1 g/m2.7; p < 0.05) and no difference between overweight hypertensive and white coat hypertension-hypertensive groups. The deceleration time of mitral early filling (DCT) was longer in hypertensive normoweight children than in normotensive overweight patients (219.5 ± 110.3 ms vs. 197.8 ± 65.8 ms; p < 0.05). A significant correlation between systolic blood pressure load (SBPL) and DCT (r = 0.57) and moderate correlation between SBPL and LVMI (r: 0.48) as well as between LVMI and isovolumetric relaxation time (r = 0.37) were found.

Conclusions: In overweight children the diagnosis of hypertension should be confirmed in ABPM because of the high prevalence of white coat hypertension. Periodic echocardiographic examinations should be recommended in overweight children with increased SBPL and decreased systolic nocturnal deep because of the possibility of LV function impairment.

Get Citation

Keywords

children; teenagers; overweight; hypertension; white coat hypertension; left ventricular function

About this article
Title

Evaluation of left ventricular function in overweight children and teenagers with arterial hypertension and white coat hypertension

Journal

Cardiology Journal

Issue

Vol 26, No 4 (2019)

Pages

343-349

Published online

2017-12-14

Page views

1552

Article views/downloads

1289

DOI

10.5603/CJ.a2017.0151

Pubmed

29240959

Bibliographic record

Cardiol J 2019;26(4):343-349.

Keywords

children
teenagers
overweight
hypertension
white coat hypertension
left ventricular function

Authors

Tomasz Floriańczyk
Małgorzata Gołąbek-Dylewska
Beata Kucińska
Bożena Werner

References (22)
  1. Menghetti E, Strisciuglio P, Spagnolo A, et al. Hypertension and obesity in Italian school children: The role of diet, lifestyle and family history. Nutr Metab Cardiovasc Dis. 2015; 25(6): 602–607.
  2. Alp H, Karaarslan S, Eklioğlu BS, et al. The effect of hypertension and obesity on left ventricular geometry and cardiac functions in children and adolescents. J Hypertens. 2014; 32(6): 1283–1292.
  3. Litwin M, Niemirska A, Ruzicka M, et al. White coat hypertension in children: not rare and not benign? J Am Soc Hypertens. 2009; 3(6): 416–423.
  4. Sorof JM, Portman RJ. White coat hypertension in children with elevated casual blood pressure. J Pediatr. 2000; 137(4): 493–497.
  5. Lande MB, Meagher CC, Fisher SG, et al. Left ventricular mass index in children with white coat hypertension. J Pediatr. 2008; 153(1): 50–54.
  6. Lobstein T, Baur L, Uauy R, et al. IASO International Obesity TaskForce. Obesity in children and young people: a crisis in public health. Obes Rev. 2004; 5 Suppl 1: 4–104.
  7. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics. 2004; 114(2 Suppl 4th Report): 555–576.
  8. Lurbe E, Agabiti-Rosei E, Cruickshank JK, et al. 2016 European Society of Hypertension guidelines for the management of high blood pressure in children and adolescents. J Hypertens. 2016; 34(10): 1887–1920.
  9. Sorof JM, Poffenbarger T, Franco K, et al. Isolated systolic hypertension, obesity, and hyperkinetic hemodynamic states in children. J Pediatr. 2002; 140(6): 660–666.
  10. Kelly AS, Barlow SE, Rao G, et al. American Heart Association Atherosclerosis, Hypertension, and Obesity in the Young Committee of the Council on Cardiovascular Disease in the Young, Council on Nutrition, Physical Activity and Metabolism, and Council on Clinical Cardiology. Severe obesity in children and adolescents: identification, associated health risks, and treatment approaches: a scientific statement from the American Heart Association. Circulation. 2013; 128(15): 1689–1712.
  11. Floriańczyk T, Wróblewska-Kałużewska M. White coat hypertension in children. Ped Pol. 2003; 78: 843–847.
  12. Lurbe E, Alvarez V, Liao Y, et al. The impact of obesity and body fat distribution on ambulatory blood pressure in children and adolescents. Am J Hypertens. 1998; 11(4 Pt 1): 418–424.
  13. Di Salvo G, Pacileo G, Del Giudice EM, et al. Abnormal myocardial deformation properties in obese, non-hypertensive children: an ambulatory blood pressure monitoring, standard echocardiographic, and strain rate imaging study. Eur Heart J. 2006; 27(22): 2689–2695.
  14. Harris KC, Al Saloos HA, De Souza AM, et al. Biophysical properties of the aorta and left ventricle and exercise capacity in obese children. Am J Cardiol. 2012; 110(6): 897–901.
  15. Lande MB, Meagher CC, Fisher SG, et al. Left ventricular mass index in children with white coat hypertension. J Pediatr. 2008; 153(1): 50–54.
  16. Daniels SR, Kimball TR, Morrison JA, et al. Effect of lean body mass, fat mass, blood pressure, and sexual maturation on left ventricular mass in children and adolescents. Statistical, biological, and clinical significance. Circulation. 1995; 92(11): 3249–3254.
  17. Mahfouz RA, Dewedar A, Abdelmoneim A, et al. Aortic and pulmonary artery stiffness and cardiac function in children at risk for obesity. Echocardiography. 2012; 29(8): 984–990.
  18. Koopman LP, McCrindle BW, Slorach C, et al. Interaction between myocardial and vascular changes in obese children: a pilot study. J Am Soc Echocardiogr. 2012; 25(4): 401–410.e1.
  19. Dhuper S, Abdullah RA, Weichbrod L, et al. Association of obesity and hypertension with left ventricular geometry and function in children and adolescents. Obesity (Silver Spring). 2011; 19(1): 128–133.
  20. Lee H, Kong YH, Kim KH, et al. Left ventricular hypertrophy and diastolic function in children and adolescents with essential hypertension. Clin Hypertens. 2015; 21: 21.
  21. Kibar AE, Pac FA, Ballı S, et al. Early subclinical left-ventricular dysfunction in obese nonhypertensive children: a tissue Doppler imaging study. Pediatr Cardiol. 2013; 34(6): 1482–1490.
  22. Shankar RR, Eckert GJ, Saha C, et al. The change in blood pressure during pubertal growth. J Clin Endocrinol Metab. 2005; 90(1): 163–167.

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Group sp. z o.o., Grupa Via Medica, ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl